Virax Biolabs Group Ltd (NASDAQ:VRAX) has launched the RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit in the European Union. What Happened: The test kits are used at home and in point-of-care ...

NEW YORK (PIX11) — The first fully FDA-approved at-home test kit to combine COVID-19 and flu tests is now available. It’s called the Healgen rapid test. The test kit is approved outside of emergency ...

FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -Lucira Health said on Monday the U.S. Food and Drug Administration (FDA) had granted emergency use ...

Home-based, self-administered tests for influenza are comparable in accuracy to rapid diagnostic tests in clinical settings, according to a recently published, peer-reviewed study. Home tests are a ...

Researchers in Southeast Asia have developed a diagnostic kit that can detect all known H5N1 influenza strains within a few hours with almost 100 percent accuracy, according to a press release by the ...

The U.S. Food and Drug Administration (FDA) just issued its first emergency use authorization for an at-home test that can tell users if they have either the flu, COVID-19, or both. The decision on ...

LONDON, March 7, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection, and diagnosis of ...

Virax Biolabs Group Ltd (NASDAQ:VRAX) shares are trading higher on abnormally high volume Tuesday after the company announced an agreement for the distribution of an Avian Influenza A Virus (AIV) real ...

A sample of the home test kit for influenza sent to participants in a Seattle study comparing home-based testing and rapid diagnostic testing in clinical settings. Disclaimer: AAAS and EurekAlert! are ...

Most of us are used to a certain routine by now for when we feel sick. If we feel a little feverish, or start coughing, we reach for an at-home testing kit that tells us, with a quick nasal swab and ...